Are you looking to commercialize your academic research?
Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that have licensed technology from universities or research institutions.
OUP has made over 50 investments to date and is currently investing out of a $215mm fund that closed in 2015. Investments are made across all stages of development from seed through growth equity with a target investment size of $5-10mm. Investment areas include:
- Life Science
- Healthcare IT
- Medical Devices & Diagnostics
Osage University Partners Senior Associate Stephanie Stehman will be in attendance to give an overview presentation about the company's key areas of interest. Following the presentation, don't miss the opportunity to introduce yourself to Stephanie during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with Osage University Partners will be facilitated to provide your company with a private forum to discuss your technology.
10:30 AM | Registration Opens and Networking
11:00 AM | Presentation and Q&A
11:45 AM | Networking Lunch
1:00-5:00 PM | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on January 9th, 2017.
Osage University Partners Participating Representative:
Stephanie Stehman | Senior Associate, Osage University Partners
Stephanie Stehman joined Osage University Partners in 2015 and focuses on investments in therapeutics, diagnostics, and medical devices. Previously, Stephanie was with H.I.G. BioVentures, a venture capital firm that makes investments in the life sciences sector.
Earlier in her career, Stephanie was a Senior Consultant with Scisive Consulting, a strategy consulting firm for healthcare businesses. At Scisive, she worked with a wide range of medical industry clients to provide strategic, financial, and business development support.
Stephanie earned her Ph.D. in Cell Biology from Columbia University where she studied the role of molecular motor proteins in cell division and holds a B.S. in Biology from Muhlenberg College.
Presentation & Lunch
CA$ 25 | General Public
CA$ 15 | Academic
CA$ 40 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on Feb 6th (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on January 9th, 2016. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of one-on-one meetings is not guaranteed as all applications must be approved.
JLABS @ Toronto
MaRS Centre, West Tower
661 University Ave, Suite 1300 [13th Floor]
About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
Save This Event
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.